Abstract
Early detection of breast cancer can be achieved through mutation detection in DNA sequences, which can be acquired through patient blood samples. Mutation detection can be performed using alignment and machine learning techniques. However, alignment techniques require reference sequences, and machine learning techniques still cannot predict index mutation and require supporting tools. Therefore, in this research, a Temporal Convolutional Network (TCN) model was proposed to detect the type and index mutation faster and without reference sequences and supporting tools. The architecture of the proposed TCN model is specifically designed for sequential labeling tasks on DNA sequence data. This allows for the detection of the mutation type of each nucleotide in the sequence, and if the nucleotide has a mutation, the index mutation can be obtained. The proposed model also uses 2-mers and 3-mers mapping techniques to improve detection performance. Based on the tests that have been carried out, the proposed TCN model can achieve the highest F1-score of 0.9443 for COSMIC dataset and 0.9629 for RSCM dataset, Additionally, the proposed TCN model can detect index mutation six times faster than BiLSTM model. Furthermore, the proposed model can detect type and index mutations based on the patient’s DNA sequence, without the need for reference sequences or other additional tools.
Funder
2022 Research, Community Service and Innovation Program, School of Electrical and Information Engineering, Bandung Institute of Technology
Publisher
Public Library of Science (PLoS)
Reference49 articles.
1. International Agency for Research on Cancer, “GLOBOCAN 2020: New Global Cancer Data.” https://www.uicc.org/news/globocan-2020-new-global-cancer-data (accessed Nov. 07, 2022).
2. Deep Learning-based Automatic Diagnosis of Breast Cancer on MRI Using Mask R-CNN for Detection Followed by ResNet50 for Classification;Y. Zhang;Acad. Radiol,2023
3. Genetics of breast cancer: a topic in evolution;S. Shiovitz;Ann. Oncol,2015
4. BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance;I. Gorodetska;J. Cancer,2019
5. Breast Cancer Risk Genes—Association Analysis in More than 113,000 Women;Breast Cancer Association Consortium;N. Engl. J. Med,2021